January 31, 2017 / 4:25 PM / a year ago

BUZZ-Aeterna Zentaris: Biggest intraday pct gain in a year

** Canadian drug developer’s U.S.-listed shares up as much as 32.69 pct at $3.45 - biggest intraday pct gain in more than a year

** Stock second-biggest pct gainer on Nasdaq

** Aeterna Zentaris on Monday announced completion of its Zoptrex pivotal late-stage clinical trial in advanced endometrial cancer; expects to report top-line results in April

** Endometrial cancer is a cancer that arises from the lining of the uterus or womb

** More than 2.3 mln shares traded, 7.2x their 30-day moving avg

** Up to Monday’s close, stock had fallen 27.78 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below